Covered recipient · General Payments record
CHRISTINE R MOUSSA
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2019–2024
$1,820.23
- Reported across 83 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $626.88 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $225.50 | 8 |
| ABBVIE INC. | $218.34 | 10 |
| Amgen Inc. | $43.88 | 2 |
| Lilly USA, LLC | $28.13 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.66 | 1 |
| PFIZER INC. | $26.41 | 2 |
| Arcutis Biotherapeutics, Inc. | $21.13 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $21.03 | 1 |
| Galderma Laboratories, L.P. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.48 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074811 | CMS |
| ABBVIE INC. | $29.06 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074813 | CMS |
| ABBVIE INC. | $13.00 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074815 | CMS |
| ABBVIE INC. | $30.68 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074817 | CMS |
| ABBVIE INC. | $9.53 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074819 | CMS |
| ABBVIE INC. | $13.67 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074821 | CMS |
| ABBVIE INC. | $12.67 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074823 | CMS |
| ABBVIE INC. | $30.85 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074825 | CMS |
| ABBVIE INC. | $31.84 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074827 | CMS |
| ABBVIE INC. | $27.56 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105074829 | CMS |
| Amgen Inc. | $15.87 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117333998 | CMS |
| Amgen Inc. | $28.01 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117334000 | CMS |
| Arcutis Biotherapeutics, Inc. | $21.13 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121040122 | CMS |
| Galderma Laboratories, L.P. | $14.80 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145317437 | CMS |
| GENZYME CORPORATION | $34.78 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139839625 | CMS |
| GENZYME CORPORATION | $32.04 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139839677 | CMS |
| GENZYME CORPORATION | $24.88 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139839687 | CMS |
| GENZYME CORPORATION | $33.84 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139839703 | CMS |
| GENZYME CORPORATION | $7.34 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139839711 | CMS |
| GENZYME CORPORATION | $30.05 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139839729 | CMS |
| GENZYME CORPORATION | $28.99 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139839761 | CMS |
| GENZYME CORPORATION | $33.58 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139839751 | CMS |
| Lilly USA, LLC | $28.13 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136122120 | CMS |
| Novartis Pharmaceuticals Corporation | $27.66 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086987960 | CMS |
| PFIZER INC. | $13.12 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131887843 | CMS |
| PFIZER INC. | $13.29 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132096615 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $21.03 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152135962 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.